Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Cytovia grants Latin American Ceplene rights to Pint Pharma

Executive Summary

Cytovia Inc., the oncology division of Immune Pharmaceuticals Inc., granted Pint Pharma GMBH rights to market and distribute Ceplene (histamine dihydrochloride) for acute myeloid leukemia in Latin America, including Argentina, Brazil, Chile, Colombia, and Mexico.

Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity
    • Includes Royalty or Profit Split Information
    • Marketing (Licensing)

Related Companies